XRAY Stock Recent News
XRAY LATEST HEADLINES
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
XRAY's Imaging strength and SureSmile growth might have lifted Q2 performance, but Byte's drag and macro pressures likely clouded the top-line momentum.
Dentsply (XRAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Provides Select Preliminary Second Quarter 2025 Results and Reaffirms 2025 Outlook Provides Select Preliminary Second Quarter 2025 Results and Reaffirms 2025 Outlook
Investors interested in Medical - Dental Supplies stocks are likely familiar with Dentsply International (XRAY) and Merit Medical (MMSI). But which of these two companies is the best option for those looking for undervalued stocks?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
XRAY gains traction with digital implants, R&D strength, and Q1 margin growth despite softness in Europe.
Explore the latest dental 3D printing market trends. Discover insights into dental segment growth, technological adoption, and 2024 revenue data of $5.2B. The market is poised to nearly double by 2033. Explore the latest dental 3D printing market trends. Discover insights into dental segment growth, technological adoption, and 2024 revenue data of $5.2B. The market is poised to nearly double by 2033.